What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Alzheimer's disease
- Pathology
His primary scientific interests are in Alzheimer's disease, Pathology, Amyloid, Pittsburgh compound B and Neurology.
His study on Alzheimer's disease is mostly dedicated to connecting different topics, such as Posterior parietal cortex.
The Pathology study combines topics in areas such as Biomarker, Central nervous system disease, Astrocytosis and In vivo.
His biological study spans a wide range of topics, including Nuclear medicine and Cognitive impairment.
His study in Pittsburgh compound B is interdisciplinary in nature, drawing from both White matter, Alzheimer's disease biomarkers, Florbetaben and Cortex.
His study looks at the intersection of Neurology and topics like Disease with Neuroscience and Positron emission tomography.
His most cited work include:
- Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. (3385 citations)
- PET imaging of amyloid deposition in patients with mild cognitive impairment (603 citations)
- Two-year follow-up of amyloid deposition in patients with Alzheimer's disease. (537 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Internal medicine, Positron emission tomography, Pathology, Alzheimer's disease and Endocrinology.
In his study, Early onset and Apolipoprotein E is inextricably linked to Oncology, which falls within the broad field of Internal medicine.
His Positron emission tomography research incorporates elements of Cognition, Neurology, Disease and Pharmacology.
His work on Amyloid and Gliosis as part of general Pathology study is frequently linked to Deposition, therefore connecting diverse disciplines of science.
His Pittsburgh compound B and Presenilin study in the realm of Alzheimer's disease connects with subjects such as Penetrance.
His research integrates issues of Young adult, Progressive supranuclear palsy, Corticobasal degeneration and Alzheimer's disease biomarkers in his study of Pittsburgh compound B.
He most often published in these fields:
- Internal medicine (38.05%)
- Positron emission tomography (38.05%)
- Pathology (23.89%)
What were the highlights of his more recent work (between 2014-2021)?
- Positron emission tomography (38.05%)
- Neurology (23.01%)
- Internal medicine (38.05%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Positron emission tomography, Neurology, Internal medicine, Dementia and Pathology.
His Positron emission tomography research includes elements of Alzheimer's disease, Cognition, Young adult and Perfusion.
His work on Pittsburgh compound B as part of his general Alzheimer's disease study is frequently connected to Penetrance, thereby bridging the divide between different branches of science.
Anders Wall interconnects Endocrinology, Standardized uptake value and Oncology in the investigation of issues within Internal medicine.
His Dementia research focuses on Predictive value of tests and how it relates to Area under the curve.
His work in the fields of Pathology, such as Gliosis and Amyloid, overlaps with other areas such as Hazard ratio.
Between 2014 and 2021, his most popular works were:
- Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease (142 citations)
- Imaging in-vivo tau pathology in Alzheimer’s disease with THK5317 PET in a multimodal paradigm (86 citations)
- Imaging in-vivo tau pathology in Alzheimer’s disease with THK5317 PET in a multimodal paradigm (86 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Alzheimer's disease
- Pathology
His main research concerns Positron emission tomography, Dementia, Neurology, Pathology and Alzheimer's disease.
His Tracer kinetic study, which is part of a larger body of work in Positron emission tomography, is frequently linked to Accuracy and precision, bridging the gap between disciplines.
His studies in Dementia integrate themes in fields like Cerebrospinal fluid and Cognition, Episodic memory.
His work investigates the relationship between Pathology and topics such as Internal medicine that intersect with problems in Oncology.
He studies Alzheimer's disease, namely Pittsburgh compound B.
His Pittsburgh compound B study incorporates themes from Progressive supranuclear palsy, Corticobasal degeneration, Young adult, Perfusion scanning and In vivo.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
